Danicamtiv

A cardiac-specific myosin activator

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥3162.00

2530.00

- +
10mg

￥5400.00

4320.00

- +
25mg

￥10800.00

8640.00

- +
50mg

￥17100.00

13680.00

- +
100mg

￥24575.00

19660.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

Danicamtiv is a cardiac-specific myosin activator.^1,2 It activates human cardiac S1 myosin when used at a concentration of 3 ?M but does not activate skeletal or smooth muscle myosin.¹ It increases sarcomere activity of isolated porcine left ventricular and atrial myofibrils with 50% active concentration values (AC₅₀s) of 6 and 3.6 ?M, respectively. Danicamtiv (3 ?M) increases calcium sensitivity of isolated porcine skinned left ventricular and atrial fibers. Danicamtiv (2-3 mg/kg) also prolongs systolic ejection time and improves left ventricular ejection fraction and stroke volume in a dog model of heart failure.

1.Voors, A.A., Tamby, J.-F., Cleland, J.G., et al.Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trialEur. J. Heart Fail.22(9)1649-1658(2020) 2.Grillo, M.P., Markova, S., Evanchik, M., et al.Preclinical in vitro and in vivo pharmacokinetic properties of danicamtiv, a new targeted myosin activator for the treatment of dilated cardiomyopathyXenobiotica51(2)222-238(2021)